| AGLX Stock | | | NOK 35.00 1.00 2.78% |
Agilyx AS potential-upside technical analysis lookup allows you to check this and other technical indicators for Agilyx AS or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also
Equity Screeners to view more equity screening tools
Agilyx AS has current Potential Upside of 2.74. Potential Upside is the amount of upward price movement an investor or an analyst expects of a particular equity instrument.
Potential Upside | = | 1PM2PM |
| = | 2.74 | |
| 1PM | = | First upper moment |
| 2PM | = | Second upper moment |
Agilyx AS Potential Upside Peers Comparison
Agilyx Potential Upside Relative To Other Indicators
Agilyx AS is rated
third in potential upside category among its peers. It is currently under evaluation in maximum drawdown category among its peers reporting about
3.02 of Maximum Drawdown per Potential Upside. The ratio of Maximum Drawdown to Potential Upside for Agilyx AS is roughly
3.02 Unlike using an educated guess on how high a stock could go calculate potential upside as the greater the potential dollar or percentage rise, the bigger the upside for the investment. Potential Upside is the reciprocal of the Value At Risk measure and can be interpreted as return on an investment relative to minimal acceptable return.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.